Calcitonin Injection Market Expansion Outlook: $0.99 Billion by 2029 Forecast

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Predicted Market Size Trajectory For The Calcitonin Injection Market From 2025 To 2034?

The calcitonin injection market has demonstrated robust expansion in recent years. Its valuation is projected to climb from $0.67 billion in 2024 to $0.73 billion by 2025, indicating a compound annual growth rate (CAGR) of 8.5%. This historical upward trend can be ascribed to the escalating prevalence of osteoporosis, heightened awareness regarding bone health, the broadening array of postmenopausal treatment options, the availability of government healthcare subsidies, and the growing geriatric population.

The calcitonin injection market is set to experience significant expansion in the coming years. It is projected to achieve a value of $0.99 billion by 2029, growing at a compound annual growth rate (CAGR) of 8.2%. This anticipated growth during the forecast period is driven by factors such as the increasing demand for various treatments, the emergence of biosimilar competition, growing demand within developing markets, a pivot towards personalized medicine approaches, and heightened research into alternative applications for calcitonin. Prominent trends throughout this period involve advancements in intranasal and injectable delivery methods, the development of advanced formulations with extended half-life, the creation of biosimilar calcitonin products, innovative strategies in osteoporosis treatment, and improvements in diagnostic tools.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24490&type=smp

What Are The Drivers Pushing New Developments In The Calcitonin Injection Market?

The rising occurrence of osteoporosis is anticipated to drive the expansion of the calcitonin injection market in the future. Osteoporosis is a medical condition defined by reduced bone density and a higher risk of fractures, predominantly impacting older individuals, particularly women after menopause. The growing incidence of osteoporosis stems from the aging global population, where extended lifespans contribute to natural bone mass decline and an elevated susceptibility to the condition. Calcitonin injection aids in managing osteoporosis by regulating calcium concentrations and decelerating bone deterioration, proving effective in preserving bone density. This treatment offers precise therapy via simple-to-administer injections, enhancing patient adherence and mitigating fracture risks. As an example, in June 2024, data from the Australian Institute of Health and Welfare, an Australia-based government entity, indicated that 853,600 people (3.4%) were living with osteoporosis or osteopenia in 2022, which accounted for 2,659 deaths, representing 1.4% of all fatalities. Consequently, the rising occurrence of osteoporosis is fueling the expansion of the calcitonin injection market.

What Are The Major Segments Identified In The Calcitonin Injection Market?

The calcitonin injection market covered in this report is segmented –

1) By Type Of Calcitonin: Salmon Calcitonin, Human Calcitonin, Synthetic Calcitonin

2) By Route Of Administration: Intravenous (IV) Injection, Subcutaneous Injection, Intramuscular Injection

3) By Distribution Channel: Direct Sales, Online Pharmacy, Retail Pharmacy, Healthcare Institutions

4) By Therapeutic Application: Osteoporosis Treatment, Pagets Disease Management, Hypercalcemia Control, Bone Metastases Therapy

5) By End-User: Hospitals, Specialty Clinics, Geriatric Care Facilities, Home Healthcare

Subsegments:

1) By Salmon Calcitonin, Synthetic Salmon Calcitonin, Recombinant Salmon Calcitonin

2) By Human Calcitonin, Recombinant Human Calcitonin, Synthetic Human Calcitonin

3) By Synthetic Calcitonin, Peptide-Based Synthetic Calcitonin, Analog Synthetic Calcitonin

How Are Emerging Market Trends Shaping The Calcitonin Injection Industry Landscape?

Leading companies in the calcitonin injection market are concentrating on developing innovative products, such as USP synthetic injections, to boost treatment effectiveness and enhance patient outcomes. USP Synthetic Injections are injectable medications containing synthetically produced active ingredients that comply with the stringent quality, purity, strength, and identity standards established by the United States Pharmacopeia (USP). These injections are manufactured under regulated conditions to ensure their safety and efficacy for therapeutic use. For instance, in February 2025, Fresenius Kabi, a Germany-based pharmaceutical company, launched calcitonin salmon injection, a USP synthetic product, for treating symptomatic Paget’s disease of the bone and hypercalcemia. This sterile solution is formulated for intramuscular or subcutaneous injection, available in a strength of 200 USP units per mL, and packaged in a 2 mL multi-dose vial containing 400 USP units. It requires refrigerated storage between 2°C and 8°C. This injectable medication functions as a calcium regulator. It is indicated for the treatment of symptomatic Paget’s disease of bone when alternative treatments are unsuitable, hypercalcemia, and postmenopausal osteoporosis when other options are not appropriate.

Which Global Market Leaders Are Shaping The Future Of The Calcitonin Injection Sector?

Major companies operating in the calcitonin injection market are Kaiser Permanente, F. Hoffmann-La Roche AG, Sanofi S.A., Novartis AG, AstraZeneca plc, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Viatris Inc., Fresenius Kabi AG, Sun Pharmaceutical Industries Limited, Dr. Reddy’s Laboratories Limited, Cipla Limited, Hikma Pharmaceuticals plc, Endo International plc, Asahi Kasei Pharma Corporation, Torrent Pharmaceuticals Limited, BCN Peptides S.L., SG Pharmaceuticals Pvt Ltd, Leucadia Pharmaceuticals Inc., Polypeptide Group AB

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/calcitonin-injection-global-market-report

Which Regional Markets Are Contributing Most To The Calcitonin Injection Industry Expansion?

North America was the largest region in the calcitonin injection market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the calcitonin injection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Calcitonin Injection Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24490&type=smp

Browse Through More Reports Similar to the Global Calcitonin Injection Market 2025, By The Business Research Company

Companion Animal Pharmaceuticals Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/companion-animal-pharmaceuticals-global-market-report

Pharmaceutical Excipient Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pharmaceutical-excipient-global-market-report

Pharmaceutical Drug Delivery Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pharmaceutical-drug-delivery-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795